1. |
黄志强. 实用临床普通外科学[M]. 北京:科学技术文献出版社, 2009:370-375.
|
2. |
Manfredi S, Lepage C, Hatem C, et al. Epidemiology and management of liver metastases from colorectal cancer[J]. Ann Surg, 2006, 244(2):254-259.
|
3. |
Mcmillan DC, Crozier JE, Canna K, et al. Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer[J]. Int J Colorectal Dis, 2007, 22(8):881-886.
|
4. |
Furukawa K, Shiba H, Haruki K, et al. The Glasgow prognostic score is valuable for colorectal cancer with both synchronous and metachronous unresectable liver metastases[J]. Oncol Lett, 2012, 4(2):324-328.
|
5. |
Ishizuka M, Nagata H, Takagi K, et al. Inflammation-based prognostic system predicts survival after surgery for stage Ⅳ colorectal cancer[J]. Am J Surg, 2013, 205(1):22-28.
|
6. |
Miller G, Biernacki P, Kemeny NE, et al. Outcomes after resectionof synchronous or metachronous hepatic and pulmonary colorectal metastases[J]. J Am Coll Surg, 2007, 205(2):231-238.
|
7. |
Richards CH, Roxburgh CS, Anderson JH, et al. Prognostic value of tumour necrosis and host inflammatory responses in colorectal cancer[J]. Br J Surg, 2012, 99(2):287-294.
|
8. |
Wang JY, Lu CY, Chu KS, et al. Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer[J]. Eur Surg Res, 2007, 39(4):245-250.
|
9. |
杨建光, 李震, 李晓霞, 等. 直肠癌术后局部复发转移的临床病理因素分析[J]. 中国普外基础与临床杂志, 2012, 19(11):1200-1203.
|
10. |
Demaria S, Pikarsky E, Karin M, et al. Cancer and inflammation:promise for biologic therapy[J]. J Immunother, 2010, 33(4):335-351.
|
11. |
陈晓敏, 刘文第. 炎症对肿瘤恶性生物学行为的影响[J]. 肿瘤基础与临床, 2008, 21(3):271-273.
|
12. |
吉登波, 崔景荣. 肿瘤的发生、发展及治疗与炎症的关系[J]. 中国新药杂志, 2010, 19(17):1551-1555.
|
13. |
Nozoe T, Mori E, Takahashi I, et al. Preoperative elevation of serum C-reactive protein as an independent prognostic indicator of colorectal carcinoma[J]. Surg Today, 2008, 38(7):597-602.
|
14. |
Ishizuka M, Nagata H, Takagi K, et al. C-reactive protein is associated with distant metastasis of T3 colorectal cancer[J]. Anticancer Res, 2012, 32(4):1409-1415.
|
15. |
刘霄, 唐菁, 李笃军. C-反应蛋白在肿瘤发生发展中的作用[J]. 生命的化学, 2011, 31(6):868-870.
|
16. |
Koike Y, Miki C, Okugawa Y, et al. Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer[J]. J Surg Oncol, 2008, 98(7):540-544.
|
17. |
Nakatsu T, Motoyama S, Maruyama K, et al. Tumoral CRPexpression in thoracic esophageal squamous cell cancers is associated with poor outcomes[J]. Surg Today, 2012, 42(7):652-658.
|
18. |
Woo Y, Hyung WJ, Obama K, et al. Elevated high-sensitivity C-reactive protein, a marker of advanced stage gastric cancer and postgastrectomy disease recurrence[J]. J Surg Oncol, 2012, 105(4):405-409.
|
19. |
Warschkow R, Tarantino I, Ukegjini K, et al. Diagnostic study and meta-analysis of C-reactive protein as a predictor of postoperative inflammatory complications after gastroesophageal cancer surgery[J]. Langenbecks Arch Surg, 2012, 397(5):727-736.
|
20. |
Shiba H, Furukawa K, Fujiwara Y, et al. Postoperative peak serum C-reactive protein predicts outcome of hepatic resection for hepatocellular carcinoma[J]. Anticancer Res, 2013, 33(2):705-709.
|
21. |
Gerhardt T, Milz S, Schepke M, et al. C-reactive protein is a prognostic indicator in patients with perihilar cholangiocarcinoma[J]. World J Gastroenterol, 2006, 12(34):5495-5500.
|
22. |
Pine JK, Fusai KG, Young R, et al. Serum C-reactive protein concentration and the prognosis of ductal adenocarcinoma of the head of pancreas[J]. Eur J Surg Oncol, 2009, 35(6):605-610.
|
23. |
Lai CC, You JF, Yeh CY, et al. Low preoperative serum albuminin colon cancer:a risk factor for poor outcome[J]. Int J Colorectal Dis, 2011, 26(4):473-481.
|
24. |
Lohsiriwat V, Lohsiriwat D, Boonnuch W, et al. Pre-operative hypoalbuminemia is a major risk factor for postoperative complications following rectal cancer surgery[J]. World J Gastroenterol, 2008, 14(8):1248-1251.
|
25. |
魏宜胜, 彭经, 洪楚原, 等. 结直肠癌术前低白蛋白血症的临床意义及预后分析[J]. 实用医学杂志, 2012, 28(5):778-780.
|